fondaparinux sodium
Drug ingredientThis chemical is an active pharmaceutical ingredient used in FDA-regulated drugs.
Where It Comes From
10 FDA-registered drug labelers
Aurobindo Pharma Limited
BrightGene Bio-Medical Technology Co., Ltd.
Dr. Reddy's Laboratories Limited
Eugia US LLC
Italfarmaco S.p.A
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Mylan Institutional LLC
Sandoz Inc.
ScinoPharm Taiwan Ltd.
Zydus Pharmaceuticals (USA) Inc.
Why It Matters
Sectors
Health
Downstream Uses
Appears in 2 drug and cosmetic product listings (FDA).
- •fondaparinux sodium
- •Arixtra
FDA Shortage Status
Whether any manufacturer currently reports this drug as in shortage on the FDA Drug Shortages database. "Active Shortage" means at least one presentation has status "current."
No Shortage
Shortage History
Each row is a separate manufacturer's FDA shortage filing — not a timeline for the drug as a whole. Multiple "current" entries are normal: each manufacturer/NDC files independently. Status reflects the manufacturer's report; reason describes their supply situation (Available, Unavailable, or to be discontinued).
to be discontinued
Fondaparinux Sodium Injection
09/29/2025Chemical Identity
CAS114870-03-0
PubChem CID636380
DTXSIDDTXSID501027612
FormulaC31H43N3Na10O49S8
Mol. Weight1728.1 g/mol
SMILESCOC1C(C(C(C(O1)COS(=O)(=O)[O-])OC2C(C(C(C(O2)C(=O)[O-])OC3C(C(C(C(O3)COS(=O)(=O)[O-])OC4C(C(C(C(O4)C(=O)[O-])OC5C(C(C(C(O5)COS(=O)(=O)[O-])O)O)NS(=O)(=O)[O-])O)O)OS(=O)(=O)[O-])NS(=O)(=O)[O-])O)OS(=O)(=O)[O-])O)NS(=O)(=O)[O-].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+]
Data Sources
6363802026-04-07
https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/name/fondaparinux sodium/cids/JSON
Archive: data/sources/pubchem_name/fondaparinux sodium.json
CAS 114870-03-02026-04-25
https://open.fda.gov/data/ndc/
Archive: data/sources/fda/ndc/ndc.json
CAS 114870-03-02026-06-13
https://api.fda.gov/drug/shortages.json
Archive: data/sources/fda/shortages/shortages.json